Conference icon

Conference

Overall and subgroup findings of the aTTom trial: A randomised comparison of continuing adjuvant tamoxifen to 10 years compared to stopping after 5 years in 6953 women with ER positive or ER untested early breast cancer

Publication status:
Published

Actions


Authors


Bowden, SJ More by this author
Handley, K More by this author
Expand authors...
Volume:
49
Pages:
S402-S402
Publication date:
2013-09-05
ISSN:
0959-8049
URN:
uuid:a036a469-47fa-4e6d-adb6-f7e8f26e55a7
Source identifiers:
441205
Local pid:
pubs:441205

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP